Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Omeros Corp (OMER)

Omeros Corp (OMER)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 696,970
  • Shares Outstanding, K 49,748
  • Annual Sales, $ 29,870 K
  • Annual Income, $ -126,760 K
  • 60-Month Beta 2.64
  • Price/Sales 6.85
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.32
  • Number of Estimates 2
  • High Estimate -0.24
  • Low Estimate -0.41
  • Prior Year -0.38
  • Growth Rate Est. (year over year) +15.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.31 +13.81%
on 02/03/20
14.17 -1.13%
on 01/28/20
+0.55 (+4.09%)
since 01/21/20
3-Month
12.31 +13.81%
on 02/03/20
15.88 -11.78%
on 12/04/19
-0.36 (-2.51%)
since 11/21/19
52-Week
12.31 +13.81%
on 02/03/20
20.92 -33.03%
on 08/20/19
+0.06 (+0.43%)
since 02/21/19

Most Recent Stories

More News
Omeros Corporation Appoints Former Amazon Treasurer Kurt Zumwalt to Board of Directors

Omeros Corporation (NASDAQ: OMER) today announced the appointment of Kurt Zumwalt, former global treasurer of Amazon.com, Inc., to Omeros' Board of Directors. He will also serve in a consulting role at...

AMZN : 2,095.97 (-2.65%)
OMER : 14.01 (+3.39%)
Relatively Good Performance Detected in Shares of Omeros Corp in the Pharmaceuticals Industry (OMER , PBH , NKTR , ZTS , MYL )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

NKTR : 23.53 (-0.59%)
OMER : 14.01 (+3.39%)
PBH : 42.40 (-0.26%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Omeros Corporation - OMER

Pomerantz LLP is investigating claims on behalf of investors of Omeros Corporation ("Omeros" or the "Company") (NASDAQ: OMER). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com...

OMER : 14.01 (+3.39%)
SmarTrend Watching for Potential Rebound in Shares of Omeros Corp After 1.65% Loss

Omeros Corp (NASDAQ:OMER) traded in a range yesterday that spanned from a low of $12.31 to a high of $12.76. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $12.94...

OMER : 14.01 (+3.39%)
After Yesterday's Rally of 1.76% Shares Could Potentially Pullback

Omeros Corp (NASDAQ:OMER) traded in a range yesterday that spanned from a low of $13.74 to a high of $14.16. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $13.87...

OMER : 14.01 (+3.39%)
2019 Glomerulonephritis Pipeline Review, H2 - Biogen Inc, Omeros Corp, Pfizer Inc & Visterra Inc - ResearchAndMarkets.com

The "Glomerulonephritis - Pipeline Review, H2 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

OMER : 14.01 (+3.39%)
PFE : 35.72 (-0.36%)
VIST : 7.51 (-2.21%)
Watch for Omeros Corp to Potentially Rebound After Falling 3.70% Yesterday

Omeros Corp (NASDAQ:OMER) traded in a range yesterday that spanned from a low of $14.00 to a high of $14.64. Yesterday, the shares fell 3.7%, which took the trading range below the 3-day low of $14.58...

OMER : 14.01 (+3.39%)
myTomorrows and Omeros Corporation Collaborate to Provide an Expanded Access Program for Narsoplimab

myTomorrows, a global health technology company, and Omeros Corporation (Nasdaq: OMER), an innovative biopharmaceutical company committed to discovering, developing and commercializing small-molecule and...

OMER : 14.01 (+3.39%)
Omeros' Newly Presented GPR174 Immuno-oncology Data at ESMO Immuno-Oncology Congress Show Inhibition of Both Checkpoint and Tumor-Promoting Factors

Omeros Corporation (Nasdaq: OMER) last week presented new data directed to its novel cancer immunotherapy target GPR174 at the European Society for Medical Oncology (ESMO) 2019 Immuno-Oncology Congress...

OMER : 14.01 (+3.39%)
Omeros Corp Rises 1.36% on Heavy Volume: Watch For Potential Pullback

Omeros Corp (NASDAQ:OMER) traded in a range yesterday that spanned from a low of $13.25 to a high of $13.68. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $13.50...

OMER : 14.01 (+3.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade OMER with:

Business Summary

Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM)...

See More

Key Turning Points

2nd Resistance Point 14.53
1st Resistance Point 14.27
Last Price 14.01
1st Support Level 13.56
2nd Support Level 13.11

See More

52-Week High 20.92
Fibonacci 61.8% 17.63
Fibonacci 50% 16.61
Fibonacci 38.2% 15.60
Last Price 14.01
52-Week Low 12.31

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar